10x Genomics Inc (TXG)
14.14
-0.78
(-5.26%)
USD |
NASDAQ |
Nov 14, 16:00
14.11
-0.02
(-0.18%)
After-Hours: 20:00
10x Genomics Revenue (Quarterly): 151.65M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 151.65M |
June 30, 2024 | 153.10M |
March 31, 2024 | 141.01M |
December 31, 2023 | 183.98M |
September 30, 2023 | 153.64M |
June 30, 2023 | 146.82M |
March 31, 2023 | 134.28M |
December 31, 2022 | 156.23M |
September 30, 2022 | 131.07M |
June 30, 2022 | 114.61M |
March 31, 2022 | 114.50M |
December 31, 2021 | 143.53M |
September 30, 2021 | 125.30M |
Date | Value |
---|---|
June 30, 2021 | 115.84M |
March 31, 2021 | 105.82M |
December 31, 2020 | 112.22M |
September 30, 2020 | 71.82M |
June 30, 2020 | 42.90M |
March 31, 2020 | 71.90M |
December 31, 2019 | 75.29M |
September 30, 2019 | 61.21M |
June 30, 2019 | 55.82M |
March 31, 2019 | 53.58M |
December 31, 2018 | 50.55M |
September 30, 2018 | 36.61M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
42.90M
Minimum
Jun 2020
183.98M
Maximum
Dec 2023
122.28M
Average
128.18M
Median
Revenue (Quarterly) Benchmarks
Omnicell Inc | 282.42M |
American Shared Hospital Services | 7.056M |
Astrana Health Inc | 478.71M |
Cryo-Cell International Inc | 8.067M |
P3 Health Partners Inc | 379.16M |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -35.75M |
Total Expenses (Quarterly) | 193.14M |
EPS Diluted (Quarterly) | -0.30 |
Enterprise Value | 1.408B |
Gross Profit Margin (Quarterly) | 70.16% |
Profit Margin (Quarterly) | -23.58% |
Earnings Yield | -10.82% |
Normalized Earnings Yield | -9.901 |